World's Best Scientists 2026 revealed!
Mark R. Pittelkow

Mark R. Pittelkow

D-Index & Metrics

Medicine

D-Index
103
Citations
36231
World Ranking
7407
National Ranking
3873

Mark R. Pittelkow publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark R. Pittelkow sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 495 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark R. Pittelkow D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark R. Pittelkow sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark R. Pittelkow is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of medical research, particularly within dermatology and related subfields. Their work spans several specialized areas, including cutaneous lymphoproliferative disorders, melanoma detection and management, and oral health pathology.

The research output of Mark R. Pittelkow covers a diverse range of topics and is represented in high-impact publications and various journals. Notable recent papers include:

  • Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC (2021, Blood)
  • Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma (2020, JCO Precision Oncology)
  • Deep learning for dermatologists: Part II. Current applications (2020, Journal of the American Academy of Dermatology)
  • Ruxolitinib Cream in the Treatment of Cutaneous Lichen Planus: A Prospective, Open-Label Study (2022, Journal of Investigative Dermatology)
  • Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model (2020, European Journal of Cancer)

Frequent collaborators in Mark R. Pittelkow's research include:

  • Aaron R. Mangold
  • David J. DiCaudo
  • Caitlin M. Brumfiel
  • Meera H. Patel
  • Kevin J. Severson

Publications are often placed in specialized dermatological and oncological journals such as:

  • Journal of the American Academy of Dermatology
  • Journal of Investigative Dermatology
  • JAAD Case Reports
  • International Journal of Dermatology
  • bioRxiv (Cold Spring Harbor Laboratory)

The main fields of study related to their work focus primarily on Medicine, with significant contributions to subfields including:

  • Dermatology
  • Epidemiology
  • Oncology
  • Pathology and Forensic Medicine
  • Periodontics

Mark R. Pittelkow's research topics include a wide range of clinical and pathological areas in dermatology and related disciplines, such as:

  • Cutaneous lymphoproliferative disorders research
  • Cutaneous Melanoma Detection and Management
  • Oral Health Pathology and Treatment
  • Nonmelanoma Skin Cancer Studies
  • Skin Diseases and Diabetes
  • Nail Diseases and Treatments
  • Lymphoma Diagnosis and Treatment

Best Publications

  • Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

    Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze

  • Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

    Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic

  • Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis

    Svetomir N. Markovic;Lori A. Erickson;Ravi D. Rao;Robert R. McWilliams

  • Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

    Gary D. Shipley;Mark R. Pittelkow;John J. Wille;Robert E. Scott

  • Overexpression of transforming growth factor α in psoriatic epidermis

    James T. Elder;Gary J. Fisher;Patricia B. Lindquist;Gregory L. Bennett

  • Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.

    Eric C. Vonderheid;Maria Grazia Bernengo;Günter Burg;Madeleine Duvic

  • Calciphylaxis: Natural history, risk factor analysis, and outcome

    Roger H. Weenig;Lindsay D. Sewell;Mark D.P. Davis;James T. McCarthy

  • Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome

    Lisa A. Boardman;Stephen N. Thibodeau;Daniel J. Schaid;Noralane M. Lindor

  • Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: Clonal analyses, growth kinetics, and cell cycle studies

    John J. Wille;Mark R. Pittelkow;Gary D. Shipley;Robert E. Scott

  • Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma

    A. J. Stingo;A. L. Clavell;D. M. Heublein;Chi-Ming Wei

  • New techniques for the in vitro culture of human skin keratinocytes and perspectives on their use for grafting of patients with extensive burns.

    Mark R. Pittelkow;Robert E. Scott

  • Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.

    Vu Thuong Nguyen;Assane Ndoye;Karl D. Bassler;Leonard D. Shultz

  • Adrenergic and Cholinergic Control in the Biology of Epidermis: Physiological and Clinical Significance

    Sergei A. Grando;Mark R. Pittelkow;Karin U. Schallreuter

  • A homozygous nonsense mutation in the β3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa

    Leena Pulkkinen;Angela M. Christiano;Donald Gerecke;D.Wolfe Wagman

  • Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes.

    Peter H. Itin;Alain Sarasin;Mark R. Pittelkow

  • Melanocytes are not absent in lesional skin of long duration vitiligo.

    Desmond J. Tobin;Nelle N. Swanson;Mark R. Pittelkow;Eva M. Peters

  • Cell Density and Culture Factors Regulate Keratinocyte Commitment to Differentiation and Expression of Suprabasal K1/K10 Keratins

    Yves Poumay;Mark R. Pittelkow

  • Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype.

    P W Cook;M Piepkorn;C H Clegg;G D Plowman

  • Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.

    J A Barnard;R Graves-Deal;M R Pittelkow;R DuBois

  • WHIM syndrome, an autosomal dominant disorder: Clinical, hematological, and molecular studies

    Robert J. Gorlin;Bruce Gelb;George A. Diaz;Karen G. Lofsness

Frequent Co-Authors

Karin U. Schallreuter
Karin U. Schallreuter University of Bradford
Robert J. Coffey
Robert J. Coffey Vanderbilt University Medical Center
Sergei A. Grando
Sergei A. Grando University of California, Irvine
Rajiv Kumar
Rajiv Kumar Mayo Clinic
Amy L. Weaver
Amy L. Weaver Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic
Thomas E. Witzig
Thomas E. Witzig Mayo Clinic
Chella S. David
Chella S. David Mayo Clinic
Joseph A. Murray
Joseph A. Murray Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can broaden your career options beyond traditional medical school. For those looking to enter the nursing field quickly, fast track LPN programs offer an accelerated route to becoming a Licensed Practical Nurse, helping you gain essential clinical skills in less time.

If your interest lies in mental health, you might consider advancing through the shortest PMHNP program, which prepares you for roles in psychiatric and mental health nursing. These programs allow you to specialize and graduate sooner.

Alternatively, if you are drawn to the administrative side of healthcare, an online bachelors in health administration can be a flexible, affordable option. For those aiming for higher leadership roles, pursuing one of the most affordable MHA programs online could enhance your credentials and open doors to executive positions.

Each pathway offers unique opportunities for specialization, advancement, and flexible learning—helping you make an informed decision about your future in healthcare.

Best Scientists Citing Mark R. Pittelkow

Trending Scientists

Recently Published Articles